Search Results (248)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa. | Academic Article |
Why?
|
| Cardiac Cell Therapy Fails to Rejuvenate the Chronically Scarred Rodent Heart. | Academic Article |
Why?
|
| Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection but Not by Vascular Infusion. | Academic Article |
Why?
|
| Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy. | Academic Article |
Why?
|
| Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors. | Academic Article |
Why?
|
| Bilateral retinal detachment after chimeric antigen receptor T-cell therapy. | Academic Article |
Why?
|
| BRAF Inhibition: Bridge or Boost to T-cell Therapy? | Academic Article |
Why?
|
| Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia. | Academic Article |
Why?
|
| Selection of bispecific antibody therapies or CAR-T cell therapy in relapsed lymphomas. | Academic Article |
Why?
|
| Suicide gene-enabled cell therapy: A novel approach to scalable human pluripotent stem cell quality control. | Academic Article |
Why?
|
| Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy. | Academic Article |
Why?
|
| 3D bioprinted mesenchymal stem cell laden scaffold enhances subcutaneous vascularization for delivery of cell therapy. | Academic Article |
Why?
|
| Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. | Academic Article |
Why?
|
| A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa. | Academic Article |
Why?
|
| Adoptive T-Cell Therapy for Cancer. | Academic Article |
Why?
|